nodes	percent_of_prediction	percent_of_DWPC	metapath
Yohimbine—ADRA2C—attention deficit hyperactivity disorder	0.244	0.305	CbGaD
Yohimbine—HTR1B—attention deficit hyperactivity disorder	0.118	0.147	CbGaD
Yohimbine—DRD3—attention deficit hyperactivity disorder	0.114	0.143	CbGaD
Yohimbine—ADRA2A—attention deficit hyperactivity disorder	0.104	0.13	CbGaD
Yohimbine—SLC6A4—attention deficit hyperactivity disorder	0.0794	0.0994	CbGaD
Yohimbine—DRD2—attention deficit hyperactivity disorder	0.0789	0.0988	CbGaD
Yohimbine—HTR2A—attention deficit hyperactivity disorder	0.061	0.0764	CbGaD
Yohimbine—HTR2A—locus ceruleus—attention deficit hyperactivity disorder	0.00361	0.0767	CbGeAlD
Yohimbine—HTR1F—forebrain—attention deficit hyperactivity disorder	0.00227	0.0482	CbGeAlD
Yohimbine—HTR2A—autonomic nervous system—attention deficit hyperactivity disorder	0.00192	0.0408	CbGeAlD
Yohimbine—HTR1F—nervous system—attention deficit hyperactivity disorder	0.00123	0.0262	CbGeAlD
Yohimbine—ADRA1D—forebrain—attention deficit hyperactivity disorder	0.0012	0.0256	CbGeAlD
Yohimbine—HTR1F—central nervous system—attention deficit hyperactivity disorder	0.00119	0.0252	CbGeAlD
Yohimbine—HTR1F—brain—attention deficit hyperactivity disorder	0.000942	0.02	CbGeAlD
Yohimbine—HTR1B—forebrain—attention deficit hyperactivity disorder	0.00093	0.0198	CbGeAlD
Yohimbine—HTR1D—forebrain—attention deficit hyperactivity disorder	0.0009	0.0191	CbGeAlD
Yohimbine—HTR2C—forebrain—attention deficit hyperactivity disorder	0.000891	0.0189	CbGeAlD
Yohimbine—DRD3—nervous system—attention deficit hyperactivity disorder	0.00087	0.0185	CbGeAlD
Yohimbine—SLC6A4—forebrain—attention deficit hyperactivity disorder	0.000845	0.018	CbGeAlD
Yohimbine—DRD3—central nervous system—attention deficit hyperactivity disorder	0.000838	0.0178	CbGeAlD
Yohimbine—HTR2B—forebrain—attention deficit hyperactivity disorder	0.000837	0.0178	CbGeAlD
Yohimbine—HTR1B—cardiovascular system—attention deficit hyperactivity disorder	0.000786	0.0167	CbGeAlD
Yohimbine—HTR1D—cardiovascular system—attention deficit hyperactivity disorder	0.000761	0.0162	CbGeAlD
Yohimbine—HTR1A—forebrain—attention deficit hyperactivity disorder	0.00075	0.0159	CbGeAlD
Yohimbine—HTR2B—cardiovascular system—attention deficit hyperactivity disorder	0.000708	0.015	CbGeAlD
Yohimbine—DRD2—forebrain—attention deficit hyperactivity disorder	0.000678	0.0144	CbGeAlD
Yohimbine—ADRA1B—nervous system—attention deficit hyperactivity disorder	0.000668	0.0142	CbGeAlD
Yohimbine—DRD3—brain—attention deficit hyperactivity disorder	0.000665	0.0141	CbGeAlD
Yohimbine—ADRA1D—nervous system—attention deficit hyperactivity disorder	0.000654	0.0139	CbGeAlD
Yohimbine—ADRA1B—central nervous system—attention deficit hyperactivity disorder	0.000643	0.0137	CbGeAlD
Yohimbine—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000634	0.0135	CbGeAlD
Yohimbine—ADRA1D—central nervous system—attention deficit hyperactivity disorder	0.000629	0.0134	CbGeAlD
Yohimbine—HTR1B—midbrain—attention deficit hyperactivity disorder	0.000614	0.013	CbGeAlD
Yohimbine—HTR1D—midbrain—attention deficit hyperactivity disorder	0.000594	0.0126	CbGeAlD
Yohimbine—HTR2C—midbrain—attention deficit hyperactivity disorder	0.000589	0.0125	CbGeAlD
Yohimbine—SLC6A4—midbrain—attention deficit hyperactivity disorder	0.000558	0.0119	CbGeAlD
Yohimbine—ADRA2A—forebrain—attention deficit hyperactivity disorder	0.000526	0.0112	CbGeAlD
Yohimbine—ADRA1B—brain—attention deficit hyperactivity disorder	0.000511	0.0109	CbGeAlD
Yohimbine—HTR1B—nervous system—attention deficit hyperactivity disorder	0.000505	0.0107	CbGeAlD
Yohimbine—ADRA1D—brain—attention deficit hyperactivity disorder	0.0005	0.0106	CbGeAlD
Yohimbine—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000495	0.0105	CbGeAlD
Yohimbine—HTR1D—nervous system—attention deficit hyperactivity disorder	0.000489	0.0104	CbGeAlD
Yohimbine—HTR1B—central nervous system—attention deficit hyperactivity disorder	0.000486	0.0103	CbGeAlD
Yohimbine—HTR2C—nervous system—attention deficit hyperactivity disorder	0.000484	0.0103	CbGeAlD
Yohimbine—HTR1D—central nervous system—attention deficit hyperactivity disorder	0.00047	0.01	CbGeAlD
Yohimbine—HTR2C—central nervous system—attention deficit hyperactivity disorder	0.000466	0.0099	CbGeAlD
Yohimbine—SLC6A4—nervous system—attention deficit hyperactivity disorder	0.000459	0.00975	CbGeAlD
Yohimbine—HTR2B—nervous system—attention deficit hyperactivity disorder	0.000455	0.00966	CbGeAlD
Yohimbine—DRD2—midbrain—attention deficit hyperactivity disorder	0.000448	0.00951	CbGeAlD
Yohimbine—HTR2A—forebrain—attention deficit hyperactivity disorder	0.000447	0.0095	CbGeAlD
Yohimbine—SLC6A4—central nervous system—attention deficit hyperactivity disorder	0.000442	0.00938	CbGeAlD
Yohimbine—HTR2B—central nervous system—attention deficit hyperactivity disorder	0.000438	0.0093	CbGeAlD
Yohimbine—ADRA2C—midbrain—attention deficit hyperactivity disorder	0.000435	0.00925	CbGeAlD
Yohimbine—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.000407	0.00866	CbGeAlD
Yohimbine—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000407	0.00866	CbGeAlD
Yohimbine—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000392	0.00833	CbGeAlD
Yohimbine—HTR1B—brain—attention deficit hyperactivity disorder	0.000386	0.0082	CbGeAlD
Yohimbine—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000383	0.00814	CbGeAlD
Yohimbine—HTR2A—cardiovascular system—attention deficit hyperactivity disorder	0.000378	0.00803	CbGeAlD
Yohimbine—HTR1D—brain—attention deficit hyperactivity disorder	0.000373	0.00794	CbGeAlD
Yohimbine—HTR2C—brain—attention deficit hyperactivity disorder	0.00037	0.00786	CbGeAlD
Yohimbine—DRD2—nervous system—attention deficit hyperactivity disorder	0.000368	0.00782	CbGeAlD
Yohimbine—ADRA2C—nervous system—attention deficit hyperactivity disorder	0.000358	0.0076	CbGeAlD
Yohimbine—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000354	0.00753	CbGeAlD
Yohimbine—SLC6A4—brain—attention deficit hyperactivity disorder	0.000351	0.00745	CbGeAlD
Yohimbine—HTR2B—brain—attention deficit hyperactivity disorder	0.000347	0.00738	CbGeAlD
Yohimbine—ADRA2A—midbrain—attention deficit hyperactivity disorder	0.000347	0.00738	CbGeAlD
Yohimbine—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000346	0.00736	CbGeAlD
Yohimbine—ADRA2C—central nervous system—attention deficit hyperactivity disorder	0.000344	0.00732	CbGeAlD
Yohimbine—ADRA2C—cerebellum—attention deficit hyperactivity disorder	0.000337	0.00715	CbGeAlD
Yohimbine—HTR1A—brain—attention deficit hyperactivity disorder	0.000311	0.00662	CbGeAlD
Yohimbine—HTR2A—midbrain—attention deficit hyperactivity disorder	0.000295	0.00627	CbGeAlD
Yohimbine—ADRA2A—nervous system—attention deficit hyperactivity disorder	0.000285	0.00607	CbGeAlD
Yohimbine—DRD2—brain—attention deficit hyperactivity disorder	0.000281	0.00598	CbGeAlD
Yohimbine—ADRA2A—central nervous system—attention deficit hyperactivity disorder	0.000275	0.00584	CbGeAlD
Yohimbine—ADRA2C—brain—attention deficit hyperactivity disorder	0.000273	0.00581	CbGeAlD
Yohimbine—ADRA2A—cerebellum—attention deficit hyperactivity disorder	0.000269	0.00571	CbGeAlD
Yohimbine—HTR2A—nervous system—attention deficit hyperactivity disorder	0.000243	0.00516	CbGeAlD
Yohimbine—HTR2A—central nervous system—attention deficit hyperactivity disorder	0.000234	0.00497	CbGeAlD
Yohimbine—HTR2A—cerebellum—attention deficit hyperactivity disorder	0.000228	0.00485	CbGeAlD
Yohimbine—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000225	0.00478	CbGeAlD
Yohimbine—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000221	0.0047	CbGeAlD
Yohimbine—ADRA2A—brain—attention deficit hyperactivity disorder	0.000218	0.00464	CbGeAlD
Yohimbine—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000216	0.0046	CbGeAlD
Yohimbine—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000213	0.00452	CbGeAlD
Yohimbine—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000208	0.00442	CbGeAlD
Yohimbine—HTR2A—brain—attention deficit hyperactivity disorder	0.000186	0.00394	CbGeAlD
Yohimbine—CYP2D6—brain—attention deficit hyperactivity disorder	0.000169	0.00359	CbGeAlD
Yohimbine—ADRA1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.52e-05	9.86e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.51e-05	9.83e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.51e-05	9.82e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.5e-05	9.74e-05	CbGpPWpGaD
Yohimbine—ADRA1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.5e-05	9.73e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.49e-05	9.67e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	1.49e-05	9.67e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.48e-05	9.62e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.48e-05	9.62e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.47e-05	9.56e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.47e-05	9.55e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	1.47e-05	9.55e-05	CbGpPWpGaD
Yohimbine—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.47e-05	9.55e-05	CbGpPWpGaD
Yohimbine—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.47e-05	9.52e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.47e-05	9.51e-05	CbGpPWpGaD
Yohimbine—HTR2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.46e-05	9.47e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.45e-05	9.42e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.45e-05	9.4e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.45e-05	9.4e-05	CbGpPWpGaD
Yohimbine—HTR2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.45e-05	9.39e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.44e-05	9.35e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.44e-05	9.32e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.43e-05	9.28e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.43e-05	9.28e-05	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	1.43e-05	9.28e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.43e-05	9.25e-05	CbGpPWpGaD
Yohimbine—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.42e-05	9.25e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.42e-05	9.24e-05	CbGpPWpGaD
Yohimbine—ADRA2C—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.42e-05	9.21e-05	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	1.42e-05	9.19e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.41e-05	9.17e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.41e-05	9.13e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.4e-05	9.11e-05	CbGpPWpGaD
Yohimbine—HTR2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.4e-05	9.1e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.4e-05	9.09e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.4e-05	9.09e-05	CbGpPWpGaD
Yohimbine—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.4e-05	9.09e-05	CbGpPWpGaD
Yohimbine—ADRA1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.4e-05	9.07e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.38e-05	8.98e-05	CbGpPWpGaD
Yohimbine—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.38e-05	8.98e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.38e-05	8.96e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.38e-05	8.95e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.38e-05	8.95e-05	CbGpPWpGaD
Yohimbine—HTR1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.38e-05	8.94e-05	CbGpPWpGaD
Yohimbine—HTR2A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	1.38e-05	8.94e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.37e-05	8.92e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.36e-05	8.85e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.36e-05	8.84e-05	CbGpPWpGaD
Yohimbine—HTR2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.36e-05	8.83e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.35e-05	8.77e-05	CbGpPWpGaD
Yohimbine—HTR1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.35e-05	8.76e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.34e-05	8.67e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.33e-05	8.65e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.33e-05	8.6e-05	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	1.32e-05	8.55e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.31e-05	8.53e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—TPH2—attention deficit hyperactivity disorder	1.3e-05	8.44e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.3e-05	8.44e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.3e-05	8.41e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.29e-05	8.4e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.29e-05	8.37e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	1.29e-05	8.35e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	1.28e-05	8.31e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—DPYD—attention deficit hyperactivity disorder	1.28e-05	8.31e-05	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	1.28e-05	8.28e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.27e-05	8.26e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.27e-05	8.25e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.27e-05	8.24e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.27e-05	8.24e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.27e-05	8.24e-05	CbGpPWpGaD
Yohimbine—HTR2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.27e-05	8.23e-05	CbGpPWpGaD
Yohimbine—HTR2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.27e-05	8.22e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.26e-05	8.15e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	1.25e-05	8.14e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.25e-05	8.12e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	1.25e-05	8.12e-05	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	1.24e-05	8.03e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.24e-05	8.02e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	1.23e-05	7.98e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.23e-05	7.95e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.2e-05	7.82e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	1.2e-05	7.76e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.19e-05	7.74e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.19e-05	7.72e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.18e-05	7.66e-05	CbGpPWpGaD
Yohimbine—DRD3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.18e-05	7.65e-05	CbGpPWpGaD
Yohimbine—ADRA1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.18e-05	7.65e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.17e-05	7.57e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	1.16e-05	7.52e-05	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.16e-05	7.5e-05	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	1.15e-05	7.48e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.15e-05	7.47e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.15e-05	7.47e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.15e-05	7.44e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.15e-05	7.44e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.14e-05	7.42e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.13e-05	7.35e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	1.12e-05	7.3e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.12e-05	7.29e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.11e-05	7.2e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.11e-05	7.2e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.11e-05	7.2e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.11e-05	7.19e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.11e-05	7.18e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.1e-05	7.14e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.07e-05	6.97e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.07e-05	6.95e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.07e-05	6.95e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.07e-05	6.95e-05	CbGpPWpGaD
Yohimbine—ADRA2B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.06e-05	6.91e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—TPH2—attention deficit hyperactivity disorder	1.06e-05	6.86e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.06e-05	6.86e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.06e-05	6.85e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.06e-05	6.85e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.05e-05	6.84e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	1.05e-05	6.8e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.04e-05	6.76e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.04e-05	6.75e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—DPYD—attention deficit hyperactivity disorder	1.04e-05	6.75e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.03e-05	6.71e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.03e-05	6.69e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.03e-05	6.69e-05	CbGpPWpGaD
Yohimbine—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.03e-05	6.67e-05	CbGpPWpGaD
Yohimbine—HTR2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.02e-05	6.64e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1e-05	6.5e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.99e-06	6.48e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	9.98e-06	6.47e-05	CbGpPWpGaD
Yohimbine—ADRA2C—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.95e-06	6.45e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.9e-06	6.43e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.82e-06	6.37e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.82e-06	6.37e-05	CbGpPWpGaD
Yohimbine—ADRA1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.79e-06	6.35e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.71e-06	6.3e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.71e-06	6.3e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.7e-06	6.29e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.7e-06	6.29e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.67e-06	6.27e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.67e-06	6.27e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—CACNA1C—attention deficit hyperactivity disorder	9.67e-06	6.27e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.62e-06	6.24e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	9.56e-06	6.2e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.35e-06	6.07e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.33e-06	6.06e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	9.31e-06	6.04e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.29e-06	6.03e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.21e-06	5.97e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.03e-06	5.86e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.03e-06	5.86e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	9.03e-06	5.86e-05	CbGpPWpGaD
Yohimbine—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	9.02e-06	5.86e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	9.02e-06	5.85e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.99e-06	5.83e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.94e-06	5.8e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Hemostasis—EP300—attention deficit hyperactivity disorder	8.93e-06	5.79e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.89e-06	5.77e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.86e-06	5.75e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.75e-06	5.68e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.7e-06	5.65e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.7e-06	5.64e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	8.69e-06	5.64e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.66e-06	5.62e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.56e-06	5.55e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.56e-06	5.55e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.51e-06	5.52e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.49e-06	5.51e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.45e-06	5.48e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—SNAP25—attention deficit hyperactivity disorder	8.45e-06	5.48e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.42e-06	5.47e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.41e-06	5.46e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	8.35e-06	5.42e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Hemostasis—EP300—attention deficit hyperactivity disorder	8.34e-06	5.41e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.29e-06	5.38e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.28e-06	5.37e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	8.19e-06	5.32e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.18e-06	5.31e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	8.15e-06	5.29e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.15e-06	5.29e-05	CbGpPWpGaD
Yohimbine—ADRA2A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	8.08e-06	5.24e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	8.05e-06	5.22e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.89e-06	5.12e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—COMT—attention deficit hyperactivity disorder	7.88e-06	5.12e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.87e-06	5.11e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.83e-06	5.08e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—MAOA—attention deficit hyperactivity disorder	7.83e-06	5.08e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.76e-06	5.04e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.64e-06	4.96e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.62e-06	4.94e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	7.6e-06	4.93e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	7.52e-06	4.88e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.51e-06	4.87e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.5e-06	4.86e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.42e-06	4.81e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.39e-06	4.8e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	7.39e-06	4.8e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	7.34e-06	4.76e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.3e-06	4.74e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.24e-06	4.7e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	7.06e-06	4.58e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	6.89e-06	4.47e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.89e-06	4.47e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	6.84e-06	4.44e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.8e-06	4.41e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.8e-06	4.41e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	6.77e-06	4.4e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Hemostasis—EP300—attention deficit hyperactivity disorder	6.77e-06	4.39e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	6.64e-06	4.31e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	6.52e-06	4.23e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—COMT—attention deficit hyperactivity disorder	6.4e-06	4.15e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—MAOA—attention deficit hyperactivity disorder	6.36e-06	4.13e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.33e-06	4.11e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.33e-06	4.11e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.3e-06	4.09e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	6.19e-06	4.02e-05	CbGpPWpGaD
Yohimbine—HTR1F—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.12e-06	3.97e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.71e-06	3.71e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.51e-06	3.58e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.5e-06	3.57e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.49e-06	3.56e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.34e-06	3.46e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.25e-06	3.41e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.24e-06	3.4e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.84e-06	3.14e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.5e-06	2.92e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	4.5e-06	2.92e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	4.43e-06	2.87e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	4.33e-06	2.81e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	4.17e-06	2.71e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	4.14e-06	2.69e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.12e-06	2.67e-05	CbGpPWpGaD
Yohimbine—HTR1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.92e-06	2.54e-05	CbGpPWpGaD
Yohimbine—HTR1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.83e-06	2.49e-05	CbGpPWpGaD
Yohimbine—HTR2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.6e-06	2.34e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.6e-06	2.34e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.43e-06	2.22e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Metabolism—EP300—attention deficit hyperactivity disorder	3.38e-06	2.19e-05	CbGpPWpGaD
Yohimbine—DRD3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.35e-06	2.17e-05	CbGpPWpGaD
Yohimbine—ADRA1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.35e-06	2.17e-05	CbGpPWpGaD
Yohimbine—ADRA2B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.03e-06	1.96e-05	CbGpPWpGaD
Yohimbine—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.92e-06	1.9e-05	CbGpPWpGaD
Yohimbine—HTR2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.91e-06	1.89e-05	CbGpPWpGaD
Yohimbine—ADRA2C—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.83e-06	1.83e-05	CbGpPWpGaD
Yohimbine—ADRA1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.78e-06	1.81e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Metabolism—EP300—attention deficit hyperactivity disorder	2.75e-06	1.78e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	2.73e-06	1.77e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	2.71e-06	1.76e-05	CbGpPWpGaD
Yohimbine—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.56e-06	1.66e-05	CbGpPWpGaD
Yohimbine—HTR2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.52e-06	1.64e-05	CbGpPWpGaD
Yohimbine—ADRA2A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.3e-06	1.49e-05	CbGpPWpGaD
Yohimbine—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	1.79e-06	1.16e-05	CbGpPWpGaD
Yohimbine—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.17e-06	7.59e-06	CbGpPWpGaD
